GAIN THERAPEUTICS INC. - COMMON STOCK

Gain Therapeutics Announces Acceptance of Late Breaking Abstract for Presentation at the International Congress of Parkinson’s Disease and Movement Disorders®

07 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Gain Therapeutics to Participate in the 2023 BTIG Virtual Biotechnology Conference

31 июл 2023 08:00:00 Источник Nasdaq GlobeNewswire

Gain Therapeutics to Present at the Jefferies Healthcare Conference

01 июн 2023 08:00:01 Источник Nasdaq GlobeNewswire

Gain Therapeutics Reports First Quarter 2023 Financial Results and Business Update

12 май 2023 08:00:00 Источник Nasdaq GlobeNewswire

Gain Therapeutics Awarded CHF 2.5 million Innosuisse Grant to Advance Lead Program in GBA1 Parkinson’s Disease

03 май 2023 09:15:00 Источник Nasdaq GlobeNewswire

Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer

12 апр 2023 16:30:00 Источник Nasdaq GlobeNewswire

Gain Therapeutics to Present Positive Preclinical Data on its GBA1 Program at the AD/PD 2023 Meeting

29 мар 2023 08:52:52 Источник Nasdaq GlobeNewswire

Gain Therapeutics Reports Full Year 2022 Financial Results and Business Update

23 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire

Gain Therapeutics to Participate in Virtual Fireside Chat On Computational Biology in Drug Discovery with Key Opinion Leaders

22 мар 2023 08:30:00 Источник Nasdaq GlobeNewswire

Gain Therapeutics Announces Grant Award by Eurostars with Innosuisse for Alpha-1 Antitrypsin Deficiency Research Program

21 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire

Gain Therapeutics to Participate in the Oppenheimer 33rd Annual Healthcare Conference

09 мар 2023 08:00:03 Источник Nasdaq GlobeNewswire

Gain Therapeutics Presents New Preclinical Data from its Gaucher Disease Program at the 19th Annual WORLDSymposium

27 фев 2023 08:00:01 Источник Nasdaq GlobeNewswire

Gain Therapeutics to Participate in Upcoming Scientific and Medical Conferences

02 фев 2023 08:00:00 Источник Nasdaq GlobeNewswire

Gain Therapeutics to Present at Sidoti Small-Cap Virtual Investor Conference

12 янв 2023 16:05:00 Источник Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Business Update

10 ноя 2022 16:02:00 Источник Nasdaq GlobeNewswire

Gain Therapeutics Presents New Preclinical Data Showing Promising Pharmacological Activity in Parkinson’s Disease Patient-Derived Dopaminergic Neurons

26 сен 2022 08:00:02 Источник Nasdaq GlobeNewswire

Gain Therapeutics Announces Promotion of Matthias Alder to Chief Executive Officer

20 сен 2022 07:30:00 Источник Nasdaq GlobeNewswire

Gain Therapeutics Presents New Preclinical Data Demonstrating Potential Disease Modifying Benefits of its Novel Brain Penetrant Small Molecule Candidate GT-02287 in Two Preclinical Models of Parkinson’s Disease

19 сен 2022 08:00:00 Источник Nasdaq GlobeNewswire

Gain Therapeutics to Present Data at Upcoming Medical Meetings

08 сен 2022 08:00:02 Источник Nasdaq GlobeNewswire

Gain Therapeutics To Participate At The H.C. Wainwright 24th Annual Global Investment Conference

06 сен 2022 08:00:03 Источник Nasdaq GlobeNewswire